Metabolism of odd-numbered, normal fatty acids in Tetrahymena pyriformis W.

Tetrahymena pyriformis W cells were grown with short- and long-chain, odd and even normal fatty acid supplements. Tris acetate addition had no effect on the fatty acyl composition of the glycerophospholipids or sphingolipids, while Tris propionate supplementation led to a marked increase in odd normal fatty acids at the expense of even normal acids in both classes of complex lipids. This enhancement of odd normal acids permitted the identification of 17:1 delta 9(n), 17:2 delta 6,9(n), 17:2 delta 9,12(n), 17:3 delta 6,9,12(n), 19:1 delta 9(n), 19:2 delta 9,12(n) and 19:3 delta 6,9,12(n) by oxidation with periodate-permanganate and examination of the short-chain fragments. Supplementation with pentadecanoic acid (15:0(n)) led to an increase in the proportions of normal C15, C17 and C19 acids. The increase in C15 acids primarily reflected a rise in 15:0(n), whereas the rise in the levels of C17 and C19 acids was accounted for by an elevation of unsaturated acids. Growth with heptadecanoic acid (17:0(n)) resulted in substantial increases in unsaturated normal C17 and C19 fatty acids, while nonadecanoic acid (19:0(n)) addition led only to an increase in the proportion of unsaturated C19 acids. Retroconversion of these saturated, odd normal long chain fatty acid supplements was limited. Supplementation with arachidic acid (20:0(n)) resulted in only a marginal increase (1.4%) in normal C20 fatty acids of both the glycerophospholipids and the mild alkali labile neutral lipids and provided no evidence that desaturation occurred. The release of 14CO2 from [1-14C]arachidic acid when incubated with the ciliates indicated that this long-chain saturate is accumulated, activated and degraded. Normal C16-C19 saturated fatty acids are substrates for the delta 9 desaturase. The delta 11 isomers arise by chain elongation. Normal C16-C19 delta 9 monoenoic acids are substrates for the delta 12 desaturase. Normal C16-C18 delta 9 monoenes, normal C16-C19 delta 9,12 dienes and 18:1 delta 11(n) are desaturated at the C-6,7 position.

Tracking the dose distribution in radiation therapy by accounting for variable anatomy.

The goal of this research is to calculate the daily and cumulative dose distribution received by the radiotherapy patient while accounting for variable anatomy, by tracking the dose distribution delivered to tissue elements (voxels) that move within the patient. Non-linear image registration techniques (i.e., thin-plate splines) are used along with a conventional treatment planning system to combine the dose distributions computed for each 3D computed tomography (CT) study taken during treatment. For a clinical prostate case, we demonstrate that there are significant localized dose differences due to systematic voxel motion in a single fraction as well as in 15 cumulative fractions. The largest positive dose differences in rectum, bladder and seminal vesicles were 29%, 2% and 24%, respectively, after the first fraction of radiation treatment compared to the planned dose. After 15 cumulative fractions, the largest positive dose differences in rectum, bladder and seminal vesicles were 23%, 32% and 18%, respectively, compared to the planned dose. A sensitivity analysis of control point placement is also presented. This method provides an important understanding of actual delivered doses and has the potential to provide quantitative information to use as a guide for adaptive radiation treatments.